Glycosylated haemoglobin (HbA1c) levels are used as an indicator of blood glucose in diabetic patients. It is formed by the conjugation of a hexose sugar to the beta-chain of haemoglobin A. HbA1c builds up in red blood cells throughout their lifetime and its levels therefore represent a record of blood glucose levels over the previous 8 weeks or so. SCIPAC offer a range of high quality monoclonal HbA1c antibodies.
| Abbreviation | HbA1c mAb |
| Variant Name | Product Code | Purity | |
|---|---|---|---|
+ |
HbA1c mAb clone H2E2 | BM300-H2E2 | |
+ |
HbA1c mAb clone N6B7 | BM300-N6B7 | |
+ |
HbA1c mAb clone P4D1 | BM300-P4D1 | |
+ |
HbA1c mAb clone S3C9 | BM300-S3C9 | |
+ |
HbA1c mAb clone U7B2 | BM300-U7B2 | |
+ |
HbA1c mAb clone V4B7 | BM300-V4B7 | |
+ |
HbA1c mAb clone Z7B2 | BM300-Z7B2 | |
+ |
HbA1c mAb clone F7C2 | BM300-F7C2 | |
+ |
HbA1c mAb clone H2B1 | BM300-H2B1 | > 90% pure |